However, IL‐36Ra functions as a physiological antagonist of IL‐36γ, potentially dampening IL‐36γ‐induced immune activation and modulating immune homeostasis within the tumor microenvironment (TME) [28]. The gene discussed is IL36G; the disease is neoplasm.